Insights On Drug Discovery

81. What Do Sponsors Want From The CDMOs Business Development Professional? 8/21/2024

    Kirsteen Keith of Immunocore takes a stab at a “killer question” about what drug development sponsors want from the BD side of CDMOs.

82. One-Stop-Shop Outsourcing Vs. Boutique CDMOs 8/21/2024

    Our moderator and panelists get into quite an open discussion about whether to select bigger, multi-service providers, or more focused external partners known as best-in-class in specific services he need.

83. My Project Manager Sticks Up For You, Your PM For Me 8/21/2024

    Here is a robust seven-minute discussion among our experienced panelists about the vital role and expectations of project managers both at CDMOs and sponsors.

84. No Strategic Outsourcing Without An Internal Strategy 8/21/2024

    Antiksha Joshi, Urmi Quality Management Consulting, and Reza Oliyai, Oliyai Consulting, stress the need to establish a coherent, internal outsourcing strategy at biotechs before looking to form strategic partnerships at CDMOs, and provide some examples.

85. Marriage Or Roofing Contractor? Metaphors For Outsourcing 8/21/2024

    Chief Editor Louis Garguilo instigates a bit of philosophic thought in panelists Sriram Naganathan, REVOLUTION Biologics, and Kirsteen Keith, Immunocore, when it comes to strategic alliances with CDMOs.

86. Switch On The Project Manager At Your CDMO 8/21/2024

    At various points during our recent Outsourced Pharma Live, our experienced outsourcers turned their attention to “turning on” the value from PMs at your CDMO.

87. The Shifting CDMO Landscape – Don't Lose Your Balance 8/21/2024

    Our panelists describe how the landscape of today’s CDMOs continues to “shift,” what that means, and how to select and form solid partnerships within the changes.

88. The Key Questions Of Strategy For Outsourcing 8/21/2024

    Chief Editor Louis Garguilo starts off our Outsourced Pharma Live with the key questions to ask about the strategic direction of your drug development and manufacturing outsourcing.

89. Decoding A B-Cell Fingerprint: All You Need To Know 7/30/2024

    Explore how, much like a fingerprint, each B-cell possesses a unique identity, and how deciphering this code can unlock a wealth of possibilities in antibody development, immunotherapy, and beyond.

90. The Power Of The Pool: Using Bulk Cultures For Clinical Trial Manufacturing 7/29/2024

    Stable bulk cultures, made highly uniform using transposase-mediated technologies, may be the key to expediting clone selection for many biopharmaceutical applications.